BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 35315496)

  • 1. A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification.
    Gao Y; Wu C; Huang J; Huang Z; Jin Z; Guo S; Tao X; Lu S; Zhang J; Zhang F; Zhai Y; Shi R; Ye P; Wu J
    Comput Biol Med; 2023 Nov; 166():107562. PubMed ID: 37847945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis.
    Roy R; Rodig S; Bielenberg D; Zurakowski D; Moses MA
    J Biol Chem; 2011 Jun; 286(23):20758-68. PubMed ID: 21493715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
    Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
    Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM12 is an independent predictor of poor prognosis in liver cancer.
    Du S; Sun L; Wang Y; Zhu W; Gao J; Pei W; Zhang Y
    Sci Rep; 2022 Apr; 12(1):6634. PubMed ID: 35459884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment.
    Malavasi E; Adamo M; Zamprogno E; Vella V; Giamas G; Gagliano T
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LUM as a novel prognostic marker and its correlation with immune infiltration in gastric cancer: a study based on immunohistochemical analysis and bioinformatics.
    Xu W; Chen S; Jiang Q; He J; Zhang F; Wang Z; Ruan C; Shi B
    BMC Gastroenterol; 2023 Dec; 23(1):455. PubMed ID: 38129820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell and spatial transcriptomics reveal POSTN
    Chen C; Guo Q; Liu Y; Hou Q; Liao M; Guo Y; Zang Y; Wang F; Liu H; Luan X; Liang Y; Guan Z; Li Y; Liu H; Dong X; Zhang X; Liu J; Xu Q
    Clin Transl Med; 2023 Dec; 13(12):e1515. PubMed ID: 38115703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A disintegrin and metalloprotease 12 contributes to colorectal cancer metastasis by regulating epithelial‑mesenchymal transition.
    Oh HH; Park YL; Park SY; Joo YE
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
    Xu J; Wang Y; Jiang J; Yin C; Shi B
    J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatively Spliced Isoforms of
    Althenayyan S; AlMuhanna MH; AlAbdulrahman A; Alghanem B; Alsagaby SA; Alfahed A; Alasiri G; Aziz MA
    J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.
    Wang R; Gao D; Chen C; Fan G; Cheng H; Tao Y; Lu J; Tian J; Wang Y; Wang Z
    Clin Transl Oncol; 2023 May; 25(5):1425-1435. PubMed ID: 36512304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
    Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
    Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of
    Chung MW; Park YL; Park SY; Joo YE
    In Vivo; 2022; 36(5):2194-2204. PubMed ID: 36099146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
    Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
    Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers.
    Tian S; Xu X; Yang X; Fan L; Jiao Y; Zheng M; Zhang S
    Front Cell Dev Biol; 2022; 10():953551. PubMed ID: 36325361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.
    Zhu H; Jiang W; Zhu H; Hu J; Tang B; Zhou Z; He X
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35315496
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.